Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958529 · ClinicalTrials.gov registry record · NA
Gastrointestinal Toleration of Inulin Products
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT00958529: Completed NA study, sponsored by University of Minnesota.
NCT00958529 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958529, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 grams of inulin products should be well tolerated and not result in a significant increase in gastrointestinal symptoms.
Interventions
- DIETARY_SUPPLEMENT Inulin Fiber Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT00958529 record still lists
NCT00958529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Inulin Fiber Supplement is the first listed.
NCT00958529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00958529 about?
NCT00958529 is a clinical study titled "Gastrointestinal Toleration of Inulin Products". The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 grams of inulin products should be well tolerated and not result in a significant increase in gastrointestinal sympt...
What is the current status of trial NCT00958529?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2008-08. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00958529?
The interventions under investigation include: Inulin Fiber Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00958529?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00958529's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia